Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3707642015 | Fusidic acid-containing product in cutaneous dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3707643013 | Product containing fusidic acid in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fusidic acid-containing product in cutaneous dose form | Is a | Product manufactured as cutaneous dose form | true | Inferred relationship | Some | ||
| Fusidic acid-containing product in cutaneous dose form | Is a | Fusidic acid-containing product | true | Inferred relationship | Some | ||
| Fusidic acid-containing product in cutaneous dose form | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Some | ||
| Fusidic acid-containing product in cutaneous dose form | Has active ingredient | Fusidate | true | Inferred relationship | Some | 1 | |
| Fusidic acid-containing product in cutaneous dose form | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Betamethasone- and fusidic acid-containing product in cutaneous dose form | Is a | True | Fusidic acid-containing product in cutaneous dose form | Inferred relationship | Some | |
| Fusidic acid- and hydrocortisone-containing product in cutaneous dose form | Is a | True | Fusidic acid-containing product in cutaneous dose form | Inferred relationship | Some | |
| Fusidic acid only product in cutaneous dose form | Is a | True | Fusidic acid-containing product in cutaneous dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR